Fig. 4.
Fig. 4. siRNA influence on TGFβ/vitamin D3–induced CD11b expression. / (A) Graphical presentation of siAM-dependent CD11b expression in Kasumi-1 cells. Black bars (▪), no TGFβ/vitamin D3treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. (B) Graphical presentation of siAGF1-dependent CD11b expression in Kasumi-1 cells. Black bars (▪), no TGFβ/vitamin D3 treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. (C) Effect of AML1/MTG8 and AML1 siRNAs on CD11b expression in Kasumi-1 cells. The graph shows the percentage of CD11b-positive Kasumi-1 cells after electroporation with the indicated siRNA followed by addition of TGFβ1/vitamin D3. (D) Graphical presentation of siAM-dependent CD11b expression in SKNO-1 cells. Black bars (▪), no TGFβ1/vitamin D3 treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. In each experiment, cells were electroporated with 200 nM of the indicated siRNA. For siRNA nomenclature and target sites, see Table 1.

siRNA influence on TGFβ/vitamin D3–induced CD11b expression.

(A) Graphical presentation of siAM-dependent CD11b expression in Kasumi-1 cells. Black bars (▪), no TGFβ/vitamin D3treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. (B) Graphical presentation of siAGF1-dependent CD11b expression in Kasumi-1 cells. Black bars (▪), no TGFβ/vitamin D3 treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. (C) Effect of AML1/MTG8 and AML1 siRNAs on CD11b expression in Kasumi-1 cells. The graph shows the percentage of CD11b-positive Kasumi-1 cells after electroporation with the indicated siRNA followed by addition of TGFβ1/vitamin D3. (D) Graphical presentation of siAM-dependent CD11b expression in SKNO-1 cells. Black bars (▪), no TGFβ1/vitamin D3 treatment; hatched bars (▧), treatment with TGFβ1/vitamin D3. In each experiment, cells were electroporated with 200 nM of the indicated siRNA. For siRNA nomenclature and target sites, see Table 1.

Close Modal

or Create an Account

Close Modal
Close Modal